Omkar Speciality Chemicals Schedules Monitoring Committee Meeting for April 15, 2026

2 min read     Updated on 08 Apr 2026, 05:43 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Omkar Speciality Chemicals Limited has scheduled a monitoring committee meeting for April 15th, 2026, under SEBI Regulation 29 compliance. The meeting will address critical restructuring matters including extinguishment of existing equity shares, issuance of 50,00,000 new shares worth INR 5,00,00,000 on private placement basis, appointment of CFO and Company Secretary, and review of CIRP costs and statutory compliances.

powered bylight_fuzz_icon
37192100

*this image is generated using AI for illustrative purposes only.

Omkar Speciality Chemicals Limited has intimated stock exchanges about its monitoring committee meeting scheduled for April 15th, 2026, in compliance with Regulation 29 of SEBI listing obligations. The company, which entered Corporate Insolvency Resolution Process (CIRP) on December 5th, 2022, will address several critical corporate restructuring matters under the supervision of Chairperson Mr. Ajit Kumar, the erstwhile Resolution Professional.

Key Agenda Items

The monitoring committee meeting will consider multiple significant proposals that reflect the company's ongoing restructuring process under the approved resolution plan. The formal intimation was sent to both BSE Limited and National Stock Exchange of India Limited on April 7th, 2026.

Equity Share Restructuring

The committee will determine record dates for extinguishment and cancellation of existing equity shares in accordance with the approved scheme:

Share Category: Details
Promoter Shares: Entire equity shares of INR 10 each, fully paid up
Public Shareholder Shares: Entire equity shares of INR 10 each, fully paid up
Action: Complete extinguishment/cancellation

New Share Issuance

A major agenda item involves approving the issuance of new equity shares under the resolution plan:

Parameter: Details
Number of Shares: 50,00,000 equity shares
Face Value: INR 10 each
Issue Price: At par
Total Consideration: INR 5,00,00,000
Issuance Method: Private Placement Basis

Financial and Operational Matters

The meeting will address several operational aspects crucial for the company's revival. The committee will approve borrowing arrangements through loan agreements without conversion options into securities. Additionally, they will consider opening an equity subscription account to facilitate the new share issuance process.

The agenda includes reviewing statutory and contractual compliances, along with adjustment and reimbursement of CIRP costs, including additional liabilities and utilization of interest earned on Performance Bank Guarantee Fixed Deposit Receipts.

Key Appointments

The committee will consider appointing key management personnel to strengthen the company's operational framework:

Position: Appointee Details
Chief Financial Officer: Mr. Mahendra Kumar Jain (PAN: AYHPJ9945Q)
Company Secretary & Compliance Officer: Mr. Kuldeep Menaria (Membership No. ACS: 68041)

Corporate Background

Omkar Speciality Chemicals Limited, incorporated with CIN L24110MH2005PLC151589, is registered in Badlapur, Maharashtra. The company entered CIRP through an order dated December 5th, 2022, under case IA 1521/2022 In C.P. (IB)/1738(MB)2017. The monitoring committee is chaired by Mr. Ajit Kumar, the erstwhile Resolution Professional, who continues to oversee the company's restructuring process from his office at Ocus Quantum, Sector 51, Gurugram.

The meeting represents a significant step in the company's resolution process, with the committee set to discuss future action plans for the organization's revival and operational restart.

Historical Stock Returns for Omkar Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.30%+10.33%-0.68%-19.63%-23.96%-44.56%

What impact will the complete extinguishment of existing equity shares have on current shareholders' recovery prospects?

How will the new private placement of 50 crore rupees be utilized to revive the company's specialty chemicals operations?

What are the key operational milestones and timeline for Omkar's business restart following this restructuring?

Omkar Speciality Chemicals
View Company Insights
View All News
like16
dislike

Omkar Speciality Chemicals' Monitoring Committee Holds Inaugural Meeting Post-NCLT Approval

2 min read     Updated on 13 Aug 2025, 08:04 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Omkar Speciality Chemicals Limited (OSCL) held the first meeting of its Monitoring Committee on August 13, marking a crucial step in its corporate restructuring process. The committee, formed after NCLT's approval of the company's resolution plan, appointed Ajit Kumar as Chairman. Key discussions included regulatory compliance, financial considerations, CIRP cost analysis, and insurance claims. This development follows OSCL's admission into CIRP on December 5, 2022, and represents a significant move towards implementing the approved resolution plan and restoring financial stability.

powered bylight_fuzz_icon
16641278

*this image is generated using AI for illustrative purposes only.

Omkar Speciality Chemicals Limited (OSCL) has taken a significant step forward in its corporate restructuring process with the first meeting of its Monitoring Committee. The committee, formed following the National Company Law Tribunal's (NCLT) approval of the company's resolution plan, convened on August 13, marking a crucial milestone in OSCL's journey towards financial stability.

Key Developments

The inaugural meeting, which lasted for two hours, addressed several critical aspects of the company's path forward:

  1. Leadership Appointment: Ajit Kumar was appointed as the Chairman of the Monitoring Committee. Kumar, who previously served as the Resolution Professional, will now oversee the implementation of the approved resolution plan.

  2. Regulatory Compliance: The committee discussed essential statutory compliances with various regulatory bodies, including the Registrar of Companies (ROC), Goods and Services Tax (GST) authorities, Income Tax department, and stock exchanges.

  3. Financial Considerations: Determination of fees for the Chairman and other implementation-related costs were on the agenda, highlighting the committee's focus on financial prudence.

  4. CIRP Cost Analysis: The meeting reviewed Corporate Insolvency Resolution Process (CIRP) costs under both "process-related" and "going concern" categories, ensuring transparency in the financial restructuring process.

  5. Insurance Claims: The committee also addressed matters related to insurance claims, though specific details were not disclosed.

Background and Future Outlook

OSCL was admitted into the Corporate Insolvency Resolution Process (CIRP) on December 5, 2022, following an order by the NCLT Mumbai Bench. The recent approval of the resolution plan on July 31 paved the way for the formation of the Monitoring Committee.

The committee's formation and its inaugural meeting represent critical steps in OSCL's efforts to navigate through its financial challenges and implement the NCLT-approved resolution plan effectively. The focus on regulatory compliance and cost management indicates a structured approach towards the company's revival.

Monitoring Committee Structure

The Monitoring Committee, constituted in compliance with the approved resolution plan, comprises key stakeholders tasked with overseeing the implementation process. Ajit Kumar, as the Chairperson, brings his experience as the erstwhile Resolution Professional to guide the committee's efforts.

Looking Ahead

As Omkar Speciality Chemicals moves forward with its restructuring process, the Monitoring Committee is expected to play a pivotal role in ensuring the smooth implementation of the resolution plan. Future meetings will likely focus on tracking progress, addressing challenges, and steering the company towards operational and financial stability.

The company's stakeholders, including investors and creditors, will be keenly watching the developments as OSCL works towards revitalizing its operations and restoring its market position in the specialty chemicals sector.

Historical Stock Returns for Omkar Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.30%+10.33%-0.68%-19.63%-23.96%-44.56%
Omkar Speciality Chemicals
View Company Insights
View All News
like20
dislike
1 Year Returns:-23.96%